Literature DB >> 23001594

Familial prostate cancer and HOXB13 founder mutations: geographic and racial/ethnic variations.

Henry T Lynch, Trudy G Shaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23001594     DOI： 10.1007/s00439-012-1226-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


× No keyword cloud information.
  16 in total

1.  Association between germline HOXB13 G84E mutation and risk of prostate cancer.

Authors:  Mohammad R Akbari; John Trachtenberg; Justin Lee; Stephanie Tam; Robert Bristow; Andrew Loblaw; Steven A Narod; Robert K Nam
Journal:  J Natl Cancer Inst       Date:  2012-07-09       Impact factor: 13.506

2.  Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.

Authors:  Heide Hellebrand; Christian Sutter; Ellen Honisch; Eva Gross; Barbara Wappenschmidt; Christian Schem; Helmut Deissler; Nina Ditsch; Verena Gress; Marion Kiechle; Claus R Bartram; Rita K Schmutzler; Dieter Niederacher; Norbert Arnold; Alfons Meindl
Journal:  Hum Mutat       Date:  2011-02-24       Impact factor: 4.878

3.  Germline mutations in HOXB13 and prostate-cancer risk.

Authors:  Charles M Ewing; Anna M Ray; Ethan M Lange; Kimberly A Zuhlke; Christiane M Robbins; Waibhav D Tembe; Kathleen E Wiley; Sarah D Isaacs; Dorhyun Johng; Yunfei Wang; Chris Bizon; Guifang Yan; Marta Gielzak; Alan W Partin; Vijayalakshmi Shanmugam; Tyler Izatt; Shripad Sinari; David W Craig; S Lilly Zheng; Patrick C Walsh; James E Montie; Jianfeng Xu; John D Carpten; William B Isaacs; Kathleen A Cooney
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

4.  Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.

Authors:  Ella R Thompson; Samantha E Boyle; Julie Johnson; Georgina L Ryland; Sarah Sawyer; David Y H Choong; Georgia Chenevix-Trench; Alison H Trainer; Geoffrey J Lindeman; Gillian Mitchell; Paul A James; Ian G Campbell
Journal:  Hum Mutat       Date:  2011-11-04       Impact factor: 4.878

5.  Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.

Authors:  X Gao; A Zacharek; D J Grignon; W Sakr; I J Powell; A T Porter; K V Honn
Journal:  Oncogene       Date:  1995-10-05       Impact factor: 9.867

6.  A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.

Authors:  Robert Karlsson; Markus Aly; Mark Clements; Lilly Zheng; Jan Adolfsson; Jianfeng Xu; Henrik Grönberg; Fredrik Wiklund
Journal:  Eur Urol       Date:  2012-07-20       Impact factor: 20.096

7.  Combined genome-wide scan for prostate cancer susceptibility genes.

Authors:  Elizabeth M Gillanders; Jianfeng Xu; Bao-li Chang; Ethan M Lange; Fredrik Wiklund; Joan E Bailey-Wilson; Agnes Baffoe-Bonnie; MaryPat Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Sarah D Isaacs; Kathleen E Wiley; Caroline E Mohai; Mika P Matikainen; Teuvo L J Tammela; S Lilly Zheng; W Mark Brown; Annika Rökman; John D Carpten; Deborah A Meyers; Patrick C Walsh; Johanna Schleutker; Henrik Gronberg; Kathleen A Cooney; William B Isaacs; Jeffrey M Trent
Journal:  J Natl Cancer Inst       Date:  2004-08-18       Impact factor: 13.506

8.  Genetic diagnosis by whole exome capture and massively parallel DNA sequencing.

Authors:  Murim Choi; Ute I Scholl; Weizhen Ji; Tiewen Liu; Irina R Tikhonova; Paul Zumbo; Ahmet Nayir; Ayşin Bakkaloğlu; Seza Ozen; Sami Sanjad; Carol Nelson-Williams; Anita Farhi; Shrikant Mane; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-27       Impact factor: 11.205

9.  Targeted capture and massively parallel sequencing of 12 human exomes.

Authors:  Sarah B Ng; Emily H Turner; Peggy D Robertson; Steven D Flygare; Abigail W Bigham; Choli Lee; Tristan Shaffer; Michelle Wong; Arindam Bhattacharjee; Evan E Eichler; Michael Bamshad; Deborah A Nickerson; Jay Shendure
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

10.  Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing.

Authors:  Andreas Gnirke; Alexandre Melnikov; Jared Maguire; Peter Rogov; Emily M LeProust; William Brockman; Timothy Fennell; Georgia Giannoukos; Sheila Fisher; Carsten Russ; Stacey Gabriel; David B Jaffe; Eric S Lander; Chad Nusbaum
Journal:  Nat Biotechnol       Date:  2009-02-01       Impact factor: 54.908
View more
  2 in total

1.  HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy.

Authors:  Cristina Villares Zabalza; Meike Adam; Christoph Burdelski; Waldemar Wilczak; Corina Wittmer; Stefan Kraft; Till Krech; Stefan Steurer; Christina Koop; Claudia Hube-Magg; Markus Graefen; Hans Heinzer; Sarah Minner; Ronald Simon; Guido Sauter; Thorsten Schlomm; Maria Christina Tsourlakis
Journal:  Oncotarget       Date:  2015-05-20

2.  Oncogenic mechanisms of HOXB13 missense mutations in prostate carcinogenesis.

Authors:  Marta Cardoso; Sofia Maia; Paula Paulo; Manuel R Teixeira
Journal:  Oncoscience       Date:  2016-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.